Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human TNFSF15/TL1A Antibody (320-587), PE

Catalog #:   FHB54012 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, lambda
Applications: ELISA, FCM
Accession: O95150
Overview

Catalog No.

FHB54012

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, lambda

Clonality

Monoclonal

Conjugation

PE

Target

TNFSF15, Vascular endothelial cell growth inhibitor, VEGI, TL1, TNF ligand-related molecule 1, Tumor necrosis factor ligand superfamily member 15,TL1A,TNF-like ligand 1A

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

O95150

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

320-587

Data Image
References

TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential., PMID:40507829

Japanese Phase 1 Study for Global Development of Anti-TL1A Antibody PF-06480605: A Randomized, Placebo-Controlled, Single-Ascending Dose Study., PMID:40065559

TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders., PMID:40010414

Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis., PMID:39321363

Targeting TNFRSF25 by agonistic antibodies and multimeric TL1A proteins co-stimulated CD8+ T cells and inhibited tumor growth., PMID:39142717

Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?, PMID:39068930

Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway., PMID:38852524

TL1A and IL-18 synergy promotes GM-CSF-dependent thymic granulopoiesis in mice., PMID:38839915

TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis., PMID:38574740

Roles of tumor necrosis factor-like ligand 1A in γδT-cell activation and psoriasis pathogenesis., PMID:38348035

Seven chromatin regulators as immune cell infiltration characteristics, potential diagnostic biomarkers and drugs prediction in hepatocellular carcinoma., PMID:37903974

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy., PMID:37337107

Protective efficacy induced by Eimeria maxima rhomboid-like protein 1 against homologous infection., PMID:36686197

Anti-TLR7 Antibody Protects Against Lupus Nephritis in NZBWF1 Mice by Targeting B Cells and Patrolling Monocytes., PMID:34868046

A novel 10-gene immune-related lncRNA signature model for the prognosis of colorectal cancer., PMID:34814366

Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis., PMID:34257516

The relationship between TNF-like protein 1A and coronary artery aneurysms in children with Kawasaki disease., PMID:34232416

TL1A (TNFSF15) genotype affects the long-term therapeutic outcomes of anti-TNFα antibodies for Crohn's disease patients., PMID:33319044

Design, development, and evaluation of the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78:K80 serotype., PMID:33298146

Signaling in TNFSF15-mediated Suppression of VEGF Production in Endothelial Cells., PMID:33185864

TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses., PMID:33177161

Bevacizumab-Conjugated Quantum Dots: In Vitro Antiangiogenic Potential and Biosafety in Rat Retina., PMID:32522096

Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF., PMID:32381123

Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps., PMID:31641233

Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease., PMID:31379829

Association of Tumor Necrosis Like factor 1 A (TL1A) and its Decoy Receptor (DcR3) with The Disease Activity and Autoantibody Production in Rheumatoid Arthritis Patients., PMID:31332995

TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion., PMID:31176785

TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity., PMID:30972074

A role for BATF3 in TH9 differentiation and T-cell-driven mucosal pathologies., PMID:30617301

Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease., PMID:30295722

Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease., PMID:30199539

Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities., PMID:30065306

TNFSF15 is likely a susceptibility gene for systemic lupus erythematosus., PMID:29803925

An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease., PMID:29436901

TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice., PMID:29254800

Hydrogen/deuterium exchange mass spectrometry and computational modeling reveal a discontinuous epitope of an antibody/TL1A Interaction., PMID:29135326

DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression., PMID:28560426

Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease., PMID:28400196

Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation., PMID:28219835

TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals., PMID:27589684

Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis., PMID:27251675

Interleukin‑12B is upregulated by decoy receptor 3 in rheumatoid synovial fibroblasts., PMID:26956410

Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia., PMID:26393680

Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation., PMID:26099067

Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells., PMID:26096340

Effects of dietary selenium on host response to necrotic enteritis in young broilers., PMID:25575447

Dietary sodium selenite affects host intestinal and systemic immune response and disease susceptibility to necrotic enteritis in commercial broilers., PMID:25387235

Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis., PMID:25161149

Effects of salinomycin and Bacillus subtilis on growth performance and immune responses in broiler chickens., PMID:25135491

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis., PMID:24850426

Datasheet
$ 292
Product specifications
50 T 292 100 T 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human TNFSF15/TL1A Antibody (320-587), PE [FHB54012]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only